Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03674255Enrolling By Invitation

Echocardiography: Value and Accuracy at REst and STress

Role: collaborator

NCT06309784Not ApplicableCompleted

Development of a Drill Guidance System to Aid Intra-operative Surgical Drilling

Role: collaborator

NCT05093192Not ApplicableCompleted

Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia

Role: collaborator

NCT05068154Unknown

Myovista vs NT Pro-BNP Heart Failure Referral Tool

Role: lead

All 4 trials loaded